共 50 条
- [21] Acute myeloid leukemia with internal tandem duplication of Fms-like tyrosine kinase 3 gene. A promising selective inhibitor: quizartinib HEMATOLOGIE, 2023, 29 (04): : 225 - 226
- [26] Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia BLOOD CANCER JOURNAL, 2024, 14 (01):
- [27] FMS-like Tyrosine Kinase 3 (FLT3) Gene as a Significant Biomarker for Acute Myeloid Leukemia BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2020, 13 (01): : 280 - 283
- [30] Successful treatment with gilteritinib for initially FMS-like tyrosine kinase 3 gene internal tandem duplications-positive elderly refractory acute myeloid leukemia that changed into FMS-like tyrosine kinase 3 gene tyrosine kinase domain-positive after cord blood transplantation GERIATRICS & GERONTOLOGY INTERNATIONAL, 2019, 19 (10) : 1063 - 1064